Royal Fund Management, LLC Novartis Ag Transaction History

Royal Fund Management, LLC

$885 Million
Q1 2025

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$80.52 - $93.75 $2.36 Million - $2.75 Million	-29,362 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$80.11 - $90.62 $136,667 - $154,597	-1,706 Reduced 5.49%	29,362 $2.58 Million
Q4 2021 Feb 11, 2022	SELL	$79.7 - $88.13 $201,880 - $223,233	-2,533 Reduced 7.54%	31,068 $2.72 Million
Q3 2021 Oct 20, 2021	SELL	$81.78 - $95.14 $236,180 - $274,764	-2,888 Reduced 7.91%	33,601 $2.75 Million
Q2 2021 Jul 26, 2021	BUY	$85.24 - $94.15 $213,611 - $235,939	2,506 Added 7.37%	36,489 $3.33 Million
Q1 2021 Apr 29, 2021	BUY	$83.5 - $98.47 $23,463 - $27,670	281 Added 0.83%	33,983 $2.9 Million
Q4 2020 Feb 02, 2021	SELL	$78.07 - $94.43 $84,471 - $102,173	-1,082 Reduced 3.11%	33,702 $3.18 Million
Q3 2020 Oct 13, 2020	BUY	$82.14 - $91.0 $413,985 - $458,640	5,040 Added 16.94%	34,784 $3.02 Million
Q2 2020 Aug 06, 2020	BUY	$80.93 - $91.1 $67,171 - $75,613	830 Added 2.87%	29,744 $2.6 Million
Q1 2020 May 08, 2020	SELL	$70.67 - $99.01 $4.05 Million - $5.68 Million	-57,339 Reduced 66.48%	28,914 $2.38 Million
Q4 2019 May 11, 2020	BUY	$84.35 - $95.37 $97,339 - $110,056	1,154 Added 1.36%	86,253 $8.17 Million
Q3 2019 May 08, 2020	BUY	$85.54 - $94.26 $168,513 - $185,692	1,970 Added 2.37%	85,099 $7.4 Million
Q2 2019 May 08, 2020	BUY	$75.4 - $92.8 $23,449 - $28,860	311 Added 0.38%	83,129 $7.59 Million
Q1 2019 May 11, 2020	BUY	$75.32 - $86.15 $140,622 - $160,842	1,867 Added 2.31%	82,818 $7.96 Million
Q4 2018 May 07, 2020	SELL	$73.66 - $82.02 $983,581 - $1.1 Million	-13,353 Reduced 14.16%	80,951 $6.95 Million
Q3 2018 May 07, 2020	SELL	$66.94 - $77.43 $123,169 - $142,471	-1,840 Reduced 1.91%	94,304 $8.13 Million
Q2 2018 May 07, 2020	SELL	$64.91 - $73.36 $117,552 - $132,854	-1,811 Reduced 1.85%	96,144 $7.26 Million
Q1 2018 May 07, 2020	BUY	$70.39 - $84.15 $125,857 - $150,460	1,788 Added 1.86%	97,955 $7.92 Million
Q4 2017 May 07, 2020	BUY	$72.33 - $77.64 $32,186 - $34,549	445 Added 0.46%	96,167 $8.07 Million
Q3 2017 May 07, 2020	SELL	$74.14 - $77.27 $106,761 - $111,268	-1,440 Reduced 1.48%	95,722 $8.22 Million
Q2 2017 May 07, 2020	BUY	N/A	8,312 Added 9.36%	97,162 $8.11 Million
Q1 2017 May 07, 2020	BUY	N/A	84,656 Added 2018.5%	88,850 $6.6 Million
Q4 2016 May 07, 2020	BUY	N/A	4,194	4,194 $305,000

Others Institutions Holding NVS

# of Institutions

1,524

Shares Held

142M

Call Options Held

1.63M

Put Options Held

1.82M

Dodge & Cox San Francisco, CA

11.8M
Shares

$1.33 Billion
0.81% of portfolio
Primecap Management CO Pasadena, CA

10.4M
Shares

$1.17 Billion
0.98% of portfolio
Dimensional Fund Advisors LP Austin, TX

8.61M
Shares

$971 Million
0.25% of portfolio
Morgan Stanley New York, NY

7.06M
Shares

$796 Million
0.06% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

6.76M
Shares

$763 Million
0.33% of portfolio

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $243B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Royal Fund Management, LLC with notifications on news.

Account